{"id":{"repo_id":"mtu","oai_identifier":"oai:digitalcommons.mtu.edu:etdr-2148"},"canonical_url":"https://search.ndltd.org/etd/mtu/oai:digitalcommons.mtu.edu:etdr-2148","repository":{"repo_id":"mtu","name":"Michigan Technological University","base_url":"https://digitalcommons.mtu.edu/do/oai/"},"display":{"title":"Mechanisms of Pathogen Inactivation in Wastewater and Pharmaceutical Applications","abstract":"Infectious diseases are a significant threat to public health. Though society enacts practices to prevent the spread of these dangerous diseases, challenges remain. Therefore, continual advancements in treatment and prevention are required. Wastewater treatment and viral clearance in pharmaceutical applications are two key health measures that prevent the spread of infections. A low-cost, low-technology biosolids treatment process was developed to improve wastewater treatment by collecting key information on storage temperature, ammonia, volatile solids, moisture content, pH, and pathogen inactivation in biosolids over long-term storage at two wastewater treatment plants located in northern climates of the United States. Inactivation of pathogens in the biosolids was enhanced by freeze-thaw cycles, intermediate moisture contents (16% total solids), and time. Biosolids required over a year of long-term storage to reach standard pathogen limits for treatment in northern climates. To improve viral clearance in therapeutic protein manufacturing, the use of arginine and buffers was studied at pH ≥ 4 to retain the stability of the final protein product. A stabilized virus membrane structure, resulting from lipid packing density or membrane proteins, hindered the inactivation efficacy of arginine and buffers. The influence of membrane properties on arginine and buffer interactions supports the inactivation mechanisms of viral membrane deformation. Increased hydrophobicity and clustering enhanced the inactivation of enveloped viruses by arginine at pH 4 and 7. Electrostatic interactions increased the inactivation of enveloped viruses by buffers at pH 4. Overall, the mechanisms for pathogen inactivation were further understood for the improvement of biosolids treatment and therapeutic protein manufacturing to facilitate the prevention of infectious diseases.","abstract_html":"Infectious diseases are a significant threat to public health. Though society enacts practices to prevent the spread of these dangerous diseases, challenges remain. Therefore, continual advancements in treatment and prevention are required. Wastewater treatment and viral clearance in pharmaceutical applications are two key health measures that prevent the spread of infections. A low-cost, low-technology biosolids treatment process was developed to improve wastewater treatment by collecting key information on storage temperature, ammonia, volatile solids, moisture content, pH, and pathogen inactivation in biosolids over long-term storage at two wastewater treatment plants located in northern climates of the United States. Inactivation of pathogens in the biosolids was enhanced by freeze-thaw cycles, intermediate moisture contents (16% total solids), and time. Biosolids required over a year of long-term storage to reach standard pathogen limits for treatment in northern climates. To improve viral clearance in therapeutic protein manufacturing, the use of arginine and buffers was studied at pH ≥ 4 to retain the stability of the final protein product. A stabilized virus membrane structure, resulting from lipid packing density or membrane proteins, hindered the inactivation efficacy of arginine and buffers. The influence of membrane properties on arginine and buffer interactions supports the inactivation mechanisms of viral membrane deformation. Increased hydrophobicity and clustering enhanced the inactivation of enveloped viruses by arginine at pH 4 and 7. Electrostatic interactions increased the inactivation of enveloped viruses by buffers at pH 4. Overall, the mechanisms for pathogen inactivation were further understood for the improvement of biosolids treatment and therapeutic protein manufacturing to facilitate the prevention of infectious diseases.","abstract_has_math":false,"creators":["Meingast, Christa L"],"institution":null,"degree_name":"Doctor of Philosophy in Environmental Engineering (PhD)","degree_level":"Open Access Dissertation","degree_discipline":"Department of Civil and Environmental Engineering","degree_department":null,"school":null,"contributors":["Veronica Webster","Caryn Heldt"],"advisors":[],"committee_chairs":[],"committee_members":["Sharon Long","Paul Doskey"],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T08:17:59Z","subjects":["biosolids","long term storage","low- cost low-tech","arginine","therapeutic protein manufacturing","enveloped virus inactivation","Biochemical and Biomolecular Engineering","Environmental Engineering","Environmental Public Health","Health Services Research"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.mtu.edu/etdr/979"],"render_values":[{"text":"https://digitalcommons.mtu.edu/etdr/979","href":"https://digitalcommons.mtu.edu/etdr/979","code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/10.37099/mtu.dc.etdr/979","outbound_label":"DOI","outbound_source":"dc:identifier","record_url":"https://doi.org/10.37099/mtu.dc.etdr/979","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://digitalcommons.mtu.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adigitalcommons.mtu.edu%3Aetdr-2148","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Veronica Webster","Caryn Heldt"]},{"key":"dc:contributor.committeemember","label":"Committee Member","values":["Sharon Long","Paul Doskey"]},{"key":"dc:creator","label":"Author","values":["Meingast, Christa L"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2020-12-01T08:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2020-01-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Department of Civil and Environmental Engineering"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Open Access Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy in Environmental Engineering (PhD)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["biosolids","long term storage","low- cost low-tech","arginine","therapeutic protein manufacturing","enveloped virus inactivation","Biochemical and Biomolecular Engineering","Environmental Engineering","Environmental Public Health","Health Services Research"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["10.37099/mtu.dc.etdr/979","https://digitalcommons.mtu.edu/etdr/979"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Infectious diseases are a significant threat to public health. Though society enacts practices to prevent the spread of these dangerous diseases, challenges remain. Therefore, continual advancements in treatment and prevention are required. Wastewater treatment and viral clearance in pharmaceutical applications are two key health measures that prevent the spread of infections. A low-cost, low-technology biosolids treatment process was developed to improve wastewater treatment by collecting key information on storage temperature, ammonia, volatile solids, moisture content, pH, and pathogen inactivation in biosolids over long-term storage at two wastewater treatment plants located in northern climates of the United States. Inactivation of pathogens in the biosolids was enhanced by freeze-thaw cycles, intermediate moisture contents (16% total solids), and time. Biosolids required over a year of long-term storage to reach standard pathogen limits for treatment in northern climates. To improve viral clearance in therapeutic protein manufacturing, the use of arginine and buffers was studied at pH ≥ 4 to retain the stability of the final protein product. A stabilized virus membrane structure, resulting from lipid packing density or membrane proteins, hindered the inactivation efficacy of arginine and buffers. The influence of membrane properties on arginine and buffer interactions supports the inactivation mechanisms of viral membrane deformation. Increased hydrophobicity and clustering enhanced the inactivation of enveloped viruses by arginine at pH 4 and 7. Electrostatic interactions increased the inactivation of enveloped viruses by buffers at pH 4. Overall, the mechanisms for pathogen inactivation were further understood for the improvement of biosolids treatment and therapeutic protein manufacturing to facilitate the prevention of infectious diseases."]},{"key":"dc:title","label":"Title","values":["Mechanisms of Pathogen Inactivation in Wastewater and Pharmaceutical Applications"]}]}],"canonical_facts":{"dc:contributor":["Veronica Webster","Caryn Heldt"],"dc:contributor.committeemember":["Sharon Long","Paul Doskey"],"dc:creator":["Meingast, Christa L"],"dc:date.available":["2020-12-01T08:00:00Z"],"dc:date.created":["2020-01-01T08:00:00Z"],"dc:description.abstract":["Infectious diseases are a significant threat to public health. Though society enacts practices to prevent the spread of these dangerous diseases, challenges remain. Therefore, continual advancements in treatment and prevention are required. Wastewater treatment and viral clearance in pharmaceutical applications are two key health measures that prevent the spread of infections. A low-cost, low-technology biosolids treatment process was developed to improve wastewater treatment by collecting key information on storage temperature, ammonia, volatile solids, moisture content, pH, and pathogen inactivation in biosolids over long-term storage at two wastewater treatment plants located in northern climates of the United States. Inactivation of pathogens in the biosolids was enhanced by freeze-thaw cycles, intermediate moisture contents (16% total solids), and time. Biosolids required over a year of long-term storage to reach standard pathogen limits for treatment in northern climates. To improve viral clearance in therapeutic protein manufacturing, the use of arginine and buffers was studied at pH ≥ 4 to retain the stability of the final protein product. A stabilized virus membrane structure, resulting from lipid packing density or membrane proteins, hindered the inactivation efficacy of arginine and buffers. The influence of membrane properties on arginine and buffer interactions supports the inactivation mechanisms of viral membrane deformation. Increased hydrophobicity and clustering enhanced the inactivation of enveloped viruses by arginine at pH 4 and 7. Electrostatic interactions increased the inactivation of enveloped viruses by buffers at pH 4. Overall, the mechanisms for pathogen inactivation were further understood for the improvement of biosolids treatment and therapeutic protein manufacturing to facilitate the prevention of infectious diseases."],"dc:identifier":["10.37099/mtu.dc.etdr/979","https://digitalcommons.mtu.edu/etdr/979"],"dc:subject":["biosolids","long term storage","low- cost low-tech","arginine","therapeutic protein manufacturing","enveloped virus inactivation","Biochemical and Biomolecular Engineering","Environmental Engineering","Environmental Public Health","Health Services Research"],"dc:title":["Mechanisms of Pathogen Inactivation in Wastewater and Pharmaceutical Applications"],"thesis:degree_discipline":["Department of Civil and Environmental Engineering"],"thesis:degree_level":["Open Access Dissertation"],"thesis:degree_name":["Doctor of Philosophy in Environmental Engineering (PhD)"]},"updated_at":"2026-11-19T08:17:59Z"}